100% Quality Guarantee
PhD-Level Technical Support
Key Features

FOXO1 (Phospho-Ser319)Transcription Factor Activity Assay (TFAB00027)

SKU TFAB00027
Product Type ELISA Kit
ELISA Type Transcription Factor Assay
Analytes FOXO1 (Phospho-Ser319)
Reactivity Human
Reactivity Mouse
Reactivity Rat
$1,437

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheet

FOXO1 (Phospho-Ser319)Transcription Factor Activity Assay

The Foxo1 Phospho-Ser319 Transcription Factor Activity Assay Kit is designed for the precise measurement of Foxo1 phosphorylation at serine 319 in various samples such as cell lysates and tissue homogenates. This kit offers high sensitivity and specificity, ensuring accurate and reproducible results for research purposes.Foxo1 is a key transcription factor involved in various cellular processes, including cell cycle regulation, apoptosis, and metabolism. Phosphorylation of Foxo1 at serine 319 can modulate its transcriptional activity, impacting gene expression related to insulin sensitivity, oxidative stress, and longevity.

This assay kit provides researchers with a valuable tool for studying the role of Foxo1 phosphorylation in various physiological and pathological conditions, including diabetes, aging, and cancer. By accurately measuring Foxo1 activity, researchers can gain insight into the molecular mechanisms underlying these diseases and potentially identify new therapeutic targets.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose